- Trials with a EudraCT protocol (127)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
127 result(s) found for: Open-angle Glaucoma AND Ocular Hypertension.
Displaying page 6 of 7.
EudraCT Number: 2020-000438-16 | Sponsor Protocol Number: LT2347-PIV-02/20 | Start Date*: 2020-07-29 | ||||||||||||||||
Sponsor Name:Laboratoires Théa S.A.S | ||||||||||||||||||
Full Title: RANDOMIZED SINGLE-BLIND CLINICAL TRIAL TO STUDY THE TOLERABILITY, EFFICACY, QUALITY OF LIFE, AND ADHERENCE OF FIXAPROST® COMPARED TO GANFORT® P IN PATIENTS WITH OPEN-ANGLE GLAUCOMA AND/OR OCULAR HY... | ||||||||||||||||||
Medical condition: Open angle glaucoma and ocular hypertension | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-004767-34 | Sponsor Protocol Number: C-05-25 | Start Date*: 2006-03-28 |
Sponsor Name:Alcon Research, Ltd. | ||
Full Title: A Six-Week, multicenter, randomized, double-masked study to evaluate the efficacy and safety of dosing once-daily Travoprost/Timolol in the morning vs. twice-daily Dorzolamide/Timolol in patients w... | ||
Medical condition: Open-angle glaucoma and ocular hypertension | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) HU (Completed) ES (Completed) LV (Completed) DE (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-005379-10 | Sponsor Protocol Number: HUS_MON_2014-01 | Start Date*: 2015-05-18 | |||||||||||
Sponsor Name:Emiliano Hernández Galilea | |||||||||||||
Full Title: Study of tear osmolarity and Quality of Life on patients treated with unpreserved latanoprost 0.005% | |||||||||||||
Medical condition: Chronic open angle glaucoma and ocular hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-001250-10 | Sponsor Protocol Number: LT2345-PIV-02/13 | Start Date*: 2013-11-06 | |||||||||||
Sponsor Name:Laboratoires Thea | |||||||||||||
Full Title: Safety and Efficacy assessment of Monoprost® (unpreserved latanoprost) in comparison with Lumigan® 0.01 % and Lumigan® 0.03% UD, in patients with open angle glaucoma or ocular hypertension, stabili... | |||||||||||||
Medical condition: glaucoma, ocular hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) ES (Completed) GR (Completed) FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-019975-30 | Sponsor Protocol Number: 35131 | Start Date*: 2010-08-24 | ||||||||||||||||
Sponsor Name:University Medical Center, Johannes Gutenberg-University Mainz | ||||||||||||||||||
Full Title: Investigation of the efficacy and safety of preoperative IOP reduction with preservative-free COSOPT-S® (dorzolamide/timolol, MSD) eye drops versus oral acetazolamide and dexamethasone eye drops an... | ||||||||||||||||||
Medical condition: Patients with glaucoma requiring trabeculectomy (filtration surgery) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-002524-12 | Sponsor Protocol Number: BNZ-20-01-2022 | Start Date*: 2023-04-13 |
Sponsor Name:AZAD Pharma AG | ||
Full Title: A prospective, phase III, multicenter, randomized, investigator-blinded, two-arm, parallel groups, non-inferiority clinical trial for the comparison of efficacy and safety of a preservative-free Br... | ||
Medical condition: GLAUCOMA , OCCULAR HYPERTENSION | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BG (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2006-003627-37 | Sponsor Protocol Number: IT-04-04 | Start Date*: 2006-09-22 | |||||||||||
Sponsor Name:ALCON ITALIA | |||||||||||||
Full Title: Hypotonic efficacy and tollerability of concomitant supply of Travoprost e Brinzolamide vs dorzolamide-timololo in fixed association in patient with glaucoma or ocular hypertension clinical study,... | |||||||||||||
Medical condition: Patient with glaucoma or ocular hypertension bilateral non controlled | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-002777-27 | Sponsor Protocol Number: CF101-231GL | Start Date*: 2011-12-30 | |||||||||||
Sponsor Name:Can-Fite BioPharma Ltd. | |||||||||||||
Full Title: A Phase 2, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of Daily CF101 Administered Orally in Subjects with Elevated Intraocular Pressure | |||||||||||||
Medical condition: patients with elevate intraocular pressure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-005222-29 | Sponsor Protocol Number: LT2347-PIII-12/13 | Start Date*: 2014-12-19 | |||||||||||
Sponsor Name:Laboratoires THÉA | |||||||||||||
Full Title: Efficacy and Safety assessment of fixed combination unpreserved Latanoprost eye drops and Timolol 0.5% (T2347) versus Xalacom® in ocular hypertensive or glaucomatous patients. Phase III, internati... | |||||||||||||
Medical condition: glaucoma, ocular hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BE (Completed) GB (Completed) ES (Completed) EE (Completed) HU (Completed) LV (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001046-41 | Sponsor Protocol Number: 07OY004 | Start Date*: 2008-12-11 | |||||||||||
Sponsor Name:Nottingham University Hospital NHS Trust (Research & Development) | |||||||||||||
Full Title: Effectiveness of GANfort® in reducing intraocular pressure in patients presenting with significantly elevated intraocular pressure | |||||||||||||
Medical condition: Primary Open Angle Glaucoma Ocular Hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002531-15 | Sponsor Protocol Number: 09/0959 | Start Date*: 2016-11-14 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:UCL Comprehensive Clinical Trials Unit | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: A phase II, open label, non-randomised, single centre, clinical trial of ANX776 in Healthy Volunteers and patients with Glaucoma, Age-Related Macular Degeneration, and Optic Neuritis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Glaucoma, Age-related Macular Degeneration, and Optic Neuritis. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-004201-29 | Sponsor Protocol Number: CM-05-08/HU | Start Date*: 2006-06-01 |
Sponsor Name:Alcon Hungarian ltd | ||
Full Title: THE EFFICACY AND SAFETY OF TIMOLOL MALEATE 0.5% COMPARED TO BRINZOLAMIDE 1% EACH GIVEN TWICE DAILY WHEN ADDED TO TRAVOPROST 0.004% GIVEN EACH EVENING IN PRIMARY OPEN-ANGLE GLAUCOMA OR OCULAR HYPERT... | ||
Medical condition: Increased intraocular pressure and glaucoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2021-000147-45 | Sponsor Protocol Number: YS001 | Start Date*: 2021-06-04 |
Sponsor Name:YONSUNG GMBH | ||
Full Title: A non-inferiority, randomized, investigator - masked, two-parallel group, phase III clinical trial, to evaluate the efficacy and safety of a preservative free formulation of latanoprost (YSLT) vers... | ||
Medical condition: GLAUCOMA, OCCULAR HYPERTENSION | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-000844-15 | Sponsor Protocol Number: A6111139 | Start Date*: 2008-10-29 | |||||||||||
Sponsor Name:Pfizer Inc. 235 East 42nd Street, NEW YORK, NY 10017. US | |||||||||||||
Full Title: A PHASE 1, OPEN-LABEL STUDY OF LATANOPROST ACID PLASMA CONCENTRATIONS IN PEDIATRIC AND ADULT GLAUCOMA PATIENTS TREATED WITH LATANOPROST 0.005% | |||||||||||||
Medical condition: GLAUCOMA | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) ES (Completed) PT (Completed) DK (Completed) PL (Ongoing) IT (Completed) GR (Completed) Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-001793-21 | Sponsor Protocol Number: CPA12001 | Start Date*: 2013-08-06 | |||||||||||
Sponsor Name:PHARMATHEN S.A. | |||||||||||||
Full Title: Efficacy and tolerability of brinzolamide in patients with elevated intraocular pressure: a double-blind, randomized, parallel, verum-controlled trial. | |||||||||||||
Medical condition: intraocular pressure increased | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-001855-10 | Sponsor Protocol Number: SNAP1 | Start Date*: 2019-01-22 | |||||||||||
Sponsor Name:Department of Ophtalmology, Rigshospitalet-Glostrup | |||||||||||||
Full Title: Steroids and Non-steroidal Anti-inflammatory drugs in the Postoperative regime after trabeculectomy. An investigator-initiated randomized study (The SNAP study) | |||||||||||||
Medical condition: Medically uncontrolled glaucoma that requires filtration surgery. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003426-24 | Sponsor Protocol Number: GLC02-19 | Start Date*: 2020-02-13 | |||||||||||
Sponsor Name:IRCCS FONDAZIONE G.B. BIETTI PER LO STUDIO E LA RICERCA IN OFTALMOLOGIA ONLUS | |||||||||||||
Full Title: 24-hour efficacy and tolerability of the tafluprost-timolol fixed association without preservatives in glaucomatous or ocular hypertensive patients already treated with latanoprost preserved with B... | |||||||||||||
Medical condition: Glaucoma or ocular hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000846-23 | Sponsor Protocol Number: LT4032-301 | Start Date*: 2018-09-16 | |||||||||||
Sponsor Name:Laboratoires THEA | |||||||||||||
Full Title: Efficacy and safety assessment of T4032 (unpreserved bimatoprost 0.01%) versus Lumigan® 0.01% in ocular hypertensive or glaucomatous patients. | |||||||||||||
Medical condition: glaucoma, ocular hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) GB (GB - no longer in EU/EEA) DE (Completed) LT (Completed) GR (Completed) BE (Completed) PL (Completed) ES (Completed) SK (Completed) CZ (Completed) LV (Completed) BG (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-000552-18 | Sponsor Protocol Number: 769 | Start Date*: 2014-01-30 |
Sponsor Name:Bausch & Lomb Incorporated | ||
Full Title: A Randomized, Multicenter, Double-Masked, Parallel-Group Study Comparing the Safety and Efficacy of BOL-303259-X 0.024% (Latanoprostene Bunod) Ophthalmic Solution With Timolol Maleate Ophthalmic ... | ||
Medical condition: Open-Angle Glaucoma or Ocular Hypertension | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Completed) BG (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-000553-45 | Sponsor Protocol Number: 770 | Start Date*: 2013-09-13 |
Sponsor Name:Bausch & Lomb Incorporated | ||
Full Title: A Randomized, Multicenter, Double-Masked, Parallel-Group Study Comparing the Safety and Efficacy of BOL-303259-X 0.024% (Latanoprostene Bunod) Ophthalmic Solution With Timolol Maleate Ophthalmic ... | ||
Medical condition: Open-Angle Glaucoma or Ocular Hypertension | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) DE (Completed) IT (Prematurely Ended) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
